RecruitingNot ApplicableNCT07438080

Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study

Sponsor

Centre Hospitalier Universitaire de la Réunion

Enrollment

300 participants

Start Date

Apr 9, 2025

Study Type

INTERVENTIONAL

Conditions

HPV

Summary

Comunity health actions are set up in populations of women aged 30 to 65 in vulnerable situations living in the outlying areas of Reunion Island. The idea is to evaluate those action on health

Eligibility

Sex: FEMALEMin Age: 30 YearsMax Age: 65 Years

Inclusion Criteria5

Aged 30 to 65,
In a vulnerable situation (beneficiary of a state or departmental social service, or referred by a charity),
Resident in one of the two municipalities targeted by the study,
Supported by the social services of one of the two municipalities targeted by the study,
Having agreed to participate in sexual health awareness meetings organized on site

Exclusion Criteria2

Refusing to participate in the study
Having had a hysterectomy

Interventions

OTHERPublic health workshop in community

1\) Cervical cancer screening awareness workshops, conducted in small groups through focus groups. -2) Proposal for an HPV self-test (vaginal self-swab to detect high-risk HPV) as part of an individual consultation for participants who are not up-to-date with their cervical cancer screening.

Locations(2)

Cegidd Saint Paul

Saint-Paul, France

CegiDD Saint Pierre

Saint-Pierre, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07438080

Related Trials

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

NCT054915127 locations

A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

NCT069791801 location

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

NCT051088701 location

Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

NCT070656301 location

Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

NCT061098702 locations